pinex comp 1000+60 mg filmovertrukne tabletter
teva b.v. - codeinphosphathemihydrat, paracetamol - filmovertrukne tabletter - 1000+60 mg
pinex comp 500+30 mg filmovertrukne tabletter
teva b.v. - codeinphosphathemihydrat, paracetamol - filmovertrukne tabletter - 500+30 mg
comboval 10+3 mg/ml infusionsvæske, opløsning
laboratoire aguettant - ibuprofennatriumdihydrat, paracetamol - infusionsvæske, opløsning - 10+3 mg/ml
paradol 1000 mg filmovertrukne tabletter
neogen n.v. - paracetamol - filmovertrukne tabletter - 1000 mg
paracet 1 g suppositorier
karo pharma as - paracetamol - suppositorier - 1 g
paracet 250 mg suppositorier
karo pharma as - paracetamol - suppositorier - 250 mg
paracet 500 mg suppositorier
karo pharma as - paracetamol - suppositorier - 500 mg
paracet 60 mg suppositorier
karo pharma as - paracetamol - suppositorier - 60 mg
provenge
dendreon uk ltd - autologe perifere blodmononukleære celler indbefattende mindst 50 millioner autologe cd54 + -celler aktiveret med prostatasyre phosphatase granulocyt-makrofag kolonistimulerende faktor - prostatiske neoplasmer - andre immunstimulerende midler - provenge er indiceret til behandling af asymptomatiske eller minimalt symptomatisk metastatisk (ikke-visceral) kastreret-resistente prostatakræft i mandlige voksne i hvem kemoterapi ikke er endnu klinisk indiceret.
zoledronic acid teva pharma
teva b.v. - zoledronsyre - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - narkotika til behandling af knoglesygdomme - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. behandling af pagets sygdom af knoglerne hos voksne.